CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 180 enrolled
Drug / intervention
Oral intake of Feihe New Formula +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02406937
NCT02406937Phase 4Completed
CompareCT.gov

Efficacy of New Stage 1 Formula on the Improvement of Gut Comfort and Gut Health

Heilongjiang Feihe Dairy Co. Ltd.·interventional·Posted Apr 2, 2015·Updated Oct 10, 2016

In Brief

A Phase 4 clinical trial evaluating Oral intake of Feihe New Formula, Oral intake of Feihe Stage 1 Formula, and 1 other intervention for Health Behavior. Completed, enrolled 180 participants across 1 site.

Detailed Summary

180 qualified subjects aged from 7 days to 90 days will be enrolled with the 144 completed in study (allowing for a 20% drop-out rate). Subjects will be randomly assigned into 3 groups, including breast feeding, commercial and new formula group. Study intervention is 12 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealth Behavior
CountriesChina
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 2, 2015
Enrollment StartJan 1, 2015
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.3 years ago

Interventions

Oral intake of Feihe New Formuladietary

Oral intake of Feihe New Formula

Oral intake of Feihe Stage 1 Formuladietary

Oral intake of Feihe Stage 1 Formula

Breast Feedingdietary

Oral intake of breast milk